Pyrimethamine is a dihydrofolate reductase inhibitor used in the treatment of parasitic conditions such as toxoplasmosis and cystoisosporiasis, where it functions by inhibiting the synthesis of DNA and… Read more















Pyrimethamine is a dihydrofolate reductase inhibitor used in the treatment of parasitic conditions such as toxoplasmosis and cystoisosporiasis, where it functions by inhibiting the synthesis of DNA and RNA in susceptible organisms. This category provides essential materials for pharmaceutical research, including the active pharmaceutical ingredient, process-related impurities, degradation products, and stable isotope labelled compounds. Laboratories rely on these high-quality reference standards to perform accurate impurity profiling and validate analytical methods, ensuring compliance with regulatory quality control requirements. Whether conducting routine batch testing or developing complex assays for mass spectrometry, researchers utilize these pyrimethamine-related compounds—including specific isomers, N-oxides, and isotopically labelled internal standards—to achieve precise and reproducible results in stability studies and drug formulation analysis.